Advanced Chemistry Development Inc

(ACD/Labs),
Ms. Tara Sinclair,
110 Yonge Street,
14th Floor,
Toronto,
Ontario. M5C 1T4

Tel: 416-368-3435 ext 297
Fax:
Email Us

Print Email to a friend

Advanced Chemistry Development, Inc., (ACD/Labs) is a global chemistry software company developing desktop and enterprise solutions to effectively utilize the wealth of scientific knowledge generated among the many branches of chemical, biochemical, and pharmaceutical R&D. Using our deep understanding of chemical disciplines, advanced mathematical algorithms, and computer science, our solutions help guide on-going research, aid decision-making, and speed the development of new chemical entities for the marketplace.

Our goal is to provide comprehensive and innovative industry-standard software solutions to our customers to help accelerate research and strengthen their competitive position. Our expertise lies in vendor-neutral spectroscopic data processing and prediction, property prediction, analytical knowledge management, and interactive reporting of scientific data. These software solutions integrate analytical data with chemical structures, and physicochemical and ADMET property prediction to help organizations protect and leverage valuable research knowledge.

Founded in 1994 and headquartered in Toronto, Canada, ACD/Labs employs a team of over 160 dedicated individuals, including many PhD level scientists from varying chemical disciplines. In 2009, ACD/Labs joined forces with Pharma Algorithms (a leader in ADME/Tox prediction). The merger represents greater possibilities for the future of in silico modeling that will benefit molecular discovery in pharmaceutics and biotechnology.

Information about ACD/Labs and its products is available at www.acdlabs.com.

Further Information: http://www.acdlabs.com



Related Products

ACD/Labs now Offering a 30-day Free Trial of ACD/MS Fragmenter
ACD/MS Fragmenter is a tool for predicting MS fragmentation of small organic molecules.

ACD/Labs Releases Updated, Free HPLC Column Selection Software
ACD/Labs teams with researchers at AstraZeneca and HiChrom to extend the number of fully characterized columns to the chromatography community.



Related news from our archive

ACD/Labs Announces an Important Investment by Sanofi-Aventis for Production Facilities in Europe
Sanofi-Aventis deploys ACD/Labs’ suite of NMR tools at five of its production facilities in France, Germany, and Hungary.